Jubilant Ingrevia's Stock Price Rises 5.05% with 'Hold' Call from MarketsMOJO

Jubilant Ingrevia, a midcap pharmaceutical and drugs company, saw a 5.05% increase in its stock price on October 3rd, 2024. This rise in stock price was accompanied by a 'Hold' call from MarketsMOJO, a leading stock market analysis platform.

The stock opened with a loss of -2.66% but quickly recovered and reached a new 52-week high of Rs.818.25. It outperformed the sector by 5.2% and has been gaining for the last three days, with a total return of 9.82% in that period. However, it also experienced high volatility with an intraday volatility of 6.14%.

Jubilant Ingrevia is currently trading higher than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a positive trend in its stock price. In comparison to the Sensex, the company's stock has performed well, with a 1-day performance of 5.78% and a 1-month performance of 20.83%.

It is important to note that this article is based on factual information and does not include any external data or sources. It is not intended to provide any recommendations or discuss potential future growth or investor interest. Jubilant Ingrevia's recent stock performance is a reflection of its strong position in the pharmaceutical and drugs industry.